CAH — Cardinal Health Share Price
0.000.00%
Last trade - 00:00- $32.54bn
- $36.41bn
- $226.83bn
- 81
- 70
- 99
- 97
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.36 | ||
| PEG Ratio (f) | 1.28 | ||
| EPS Growth (f) | 13.62% | ||
| Dividend Yield (f) | 1.54% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.15 | ||
| EV to EBITDA | 13.85 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.06% | ||
| Return on Equity | n/a | ||
| Operating Margin | 0.85% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 152,922 | 162,467 | 181,326 | 204,979 | 226,827 | 223,115.17 | 242,659.71 | 9.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +47.27 | -14.27 | -14.62 | +18.51 | +32.85 | +17.88 | +12.73 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Directors
- Gregory Kenny NEC (68)
- Michael Kaufmann CEO (59)
- Jason Hollar CFO (48)
- Victor Crawford CEX (60)
- Stephen Mason CEX (50)
- Ola Snow CHO (54)
- Brian Rice EVP (58)
- Michele Holcomb EVP (53)
- Jessica Mayer CCO (52)
- Carrie Cox IND (64)
- Bruce Downey IND (73)
- Sheri Edison IND (64)
- David Evans IND (58)
- Patricia Hemingway Hall IND (68)
- Akhil Johri IND (60)
- Nancy Killefer IND (67)
- Dean Scarborough IND (65)
- John Weiland IND (65)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 16th, 1979
- Public Since
- August 4th, 1983
- No. of Shareholders
- 6,238
- No. of Employees
- 48,900
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 241,567,993
- Address
- 7000 Cardinal Pl, DUBLIN, 43017
- Web
- https://www.cardinalhealth.com/en.html
- Phone
- +1 6147573033
- Contact
- Matt Sims
- Auditors
- Ernst & Young LLP
Upcoming Events for CAH
Q3 2025 Cardinal Health Inc Earnings Release
Cardinal Health Inc Health Investor Day
Q4 2025 Cardinal Health Inc Earnings Release
Similar to CAH
Abbvie
New York Stock Exchange
Bausch Health Companies
New York Stock Exchange
Bristol-Myers Squibb Co
New York Stock Exchange
Bristol-Myers Squibb Co
New York Stock Exchange
Dr Reddy's Laboratories
New York Stock Exchange
FAQ
What is the Cardinal Health share price?
As of Today at 19:48 UTC, shares in Cardinal Health are trading at $134.71. This share price information is delayed by 15 minutes.
How has the Cardinal Health share price performed this year?
Shares in Cardinal Health last closed at $134.71 and the price had moved by +26.46% over the past 365 days. In terms of relative price strength the Cardinal Health share price has outperformed the S&P500 Index by +18.91% over the past year.
What are the analyst and broker recommendations for Cardinal Health?
The overall consensus recommendation for Cardinal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Cardinal Health dividend yield?
The Cardinal Health dividend yield is 1.5% based on the trailing twelve month period.
Does Cardinal Health pay a dividend?
Last year, Cardinal Health paid a total dividend of $2.02, and it currently has a trailing dividend yield of 1.5%. We do not have any data on when Cardinal Health is to next pay dividends.
When does Cardinal Health next pay dividends?
We do not have data on when Cardinal Health is to next pay dividends. The historic dividend yield on Cardinal Health shares is currently 1.5%.
How do I buy Cardinal Health shares?
To buy shares in Cardinal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cardinal Health?
As of the previous close price of $134.71, shares in Cardinal Health had a market capitalisation of $32.54bn.
Where are Cardinal Health shares listed?
Here are the trading details for Cardinal Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CAH
What kind of share is Cardinal Health?
Based on an overall assessment of its quality, value and momentum Cardinal Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cardinal Health share price forecast for 2025?
The analyst consensus target price for shares in Cardinal Health is $145.01. That is 7.65% above the last closing price of $134.71.
Analysts covering Cardinal Health currently have a consensus Earnings Per Share (EPS) forecast of $7.96 for the next financial year.
Find out moreWhat is the trend in the Cardinal Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cardinal Health. Over the past six months, its share price has outperformed the S&P500 Index by +32.8%.
As of the last closing price of $134.71, shares in Cardinal Health were trading +14.96% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cardinal Health PE Ratio?
The Cardinal Health PE ratio based on its reported earnings over the past 12 months is 15.36. The shares last closed at $134.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cardinal Health?
Cardinal Health's management team is headed by:
- Gregory Kenny - NEC
- Michael Kaufmann - CEO
- Jason Hollar - CFO
- Victor Crawford - CEX
- Stephen Mason - CEX
- Ola Snow - CHO
- Brian Rice - EVP
- Michele Holcomb - EVP
- Jessica Mayer - CCO
- Carrie Cox - IND
- Bruce Downey - IND
- Sheri Edison - IND
- David Evans - IND
- Patricia Hemingway Hall - IND
- Akhil Johri - IND
- Nancy Killefer - IND
- Dean Scarborough - IND
- John Weiland - IND